Norms and standardization of the Brief Assessment of Cognition in Schizophrenia (BACS)

KEEFE, R, HARVEY, P, GOLDBERG, T, GOLD, J, WALKER, T, KENNEL, C, HAWKINS, K·2008·Schizophrenia Research

Cited by (342)

Items 101–200 of 342

  1. Plasma total antioxidant status and cognitive impairments in first-episode drug-naïve patients with schizophrenia
    Ting Xie, Qiongwei Li, Xingguang Luο, Li Tian, Zhiren Wang, Shuping Tan, Song Chen, Guigang Yang, Huimei An, Fude Yang et al. · 2019 · Cognitive Neurodynamics
  2. Going up in Smoke? A Review of nAChRs-based Treatment Strategies for Improving Cognition in Schizophrenia
    Douglas Lee Boggs, Jon Carlson, Jose Cortes-Briones, John Harrison Krystal, Deepak Cyril D’Souza · 2014 · Current Pharmaceutical Design
  3. Trajectories of symptom severity and functioning over a three-year period in a psychosis high-risk sample: A secondary analysis of the Neurapro trial
    Jessica Hartmann, Stefanie J. Schmidt, Patrick D. McGorry, Maximus Berger, Gregor Emanuel Berger, Eric Yu Hai Chen, Lieuwe de Haan, Ian Bernard Hickie, Suzie Lavoie, Connie Markulev et al. · 2019 · Behaviour Research and Therapy
  4. Neurocognition and social cognition in patients with schizophrenia spectrum disorders with and without a history of violence: results of a multinational European study
    Laura Iozzino, Philip D. Harvey, Nicola Canessa, Paweł Gosek, Janusz Heitzman, Ambra Macis, Marco Picchioni, Hans Joachim Salize, Johannes Wancata, Marlene Koch et al. · 2021 · Translational Psychiatry
  5. Smartphone digital phenotyping, surveys, and cognitive assessments for global mental health: Initial data and clinical correlations from an international first episode psychosis study
    Tanvi Lakhtakia, Ameya P. Bondre, Prabhat Chand, Nirmal Chaturvedi, Soumya Choudhary, Danielle Currey, Siddharth Dutt, Azaz Khan, Mohit Kumar, Snehil Gupta et al. · 2022 · Digital Health
  6. Do People with Schizophrenia Lack Emotional Intelligence?
    Sara Dawson, Lisa J. Kettler, Cassandra A. Burton, Cherrie Ann Galletly · 2012 · Schizophrenia Research and Treatment
  7. Validation of the P ersian version of the Brief Assessment of Cognition in Schizophrenia in patients with schizophrenia and healthy controls
    Shahrzad Mazhari, Nooshin Parvaresh, Mahin Eslami Shahrbabaki, Mohammad Sadeghi, Nouzar Nakhaee, Richard S.E. Keefe · 2013 · Psychiatry and Clinical Neurosciences
  8. Alterations in intrinsic fronto‐thalamo‐parietal connectivity are associated with cognitive control deficits in psychotic disorders
    Rebekka Lencer, Yao Li, James L. Reilly, Sarah Keedy, Jennifer E. McDowell, Matcheri S. Keshavan, Godfrey D. Pearlson, Carol A. Tamminga, Elliot S. Gershon, Brett A. Clementz et al. · 2018 · Human Brain Mapping
  9. Cognition in schizophrenia improves with treatment of severe obstructive sleep apnoea: A pilot study
    Hannah Myles, Nicholas Myles, Ching Li Chai‐Coetzer, Robert J. Adams, Madhu Chandratilleke, Dennis Liu, Jeremy Mercer, Andrew Vakulin, Andrew D. Vincent, Gary Wittert et al. · 2018 · Schizophrenia Research Cognition
  10. Metamemory in schizophrenia: Retrospective confidence ratings interact with neurocognitive deficits
    Sarah Eifler, Franziska Rausch, Frederike N. Schirmbeck, Ruth Veckenstedt, Daniela U. Mier, Christine Esslinger, Susanne Englisch, Andreas Meyer‐Lindenberg, Peter Kirsch, Mathias Zink · 2014 · Psychiatry Research
  11. Increased serum levels of cysteine in patients with schizophrenia: A potential marker of cognitive function preservation
    Liang‐Jen Wang, Pao‐Yen Lin, Yu Lee, Yu‐Chi Huang, Chih‐Ching Wu, Su‐Ting Hsu, Chien-Chih Chen, Mian‐Yoon Chong, Chieh‐Hsin Lin, Chi‐Fa Hung · 2017 · Schizophrenia Research
  12. Basic auditory processing deficits and their association with auditory emotion recognition in schizophrenia
    Michael Kraus, Trina M. Walker, L. Fredrik Jarskog, Robert A. Millet, Richard S.E. Keefe · 2018 · Schizophrenia Research
  13. Modelling of self‐management in schizophrenia: The role of neurocognition, self‐efficacy and motivation
    Chenxi Zhou, Zheng Li · 2020 · Journal of Clinical Nursing
  14. Cognitive performances across individuals at high genetic risk for schizophrenia, high genetic risk for bipolar disorder, and low genetic risks: a combined polygenic risk score approach
    Kazutaka Ohi, Daisuke Nishizawa, Shunsuke Sugiyama, Kentaro Takai, Daisuke Fujikane, Ayumi Kuramitsu, Junko Hasegawa, Midori Soda, Kiyoyuki Kitaichi, Ryota Hashimoto et al. · 2022 · Psychological Medicine
  15. The Schizophrenia Cognition Rating Scale: Validation of an interview-based assessment of cognitive functioning in Asian patients with schizophrenia
    Ming Ying Chia, Wai Yen Chan, Kok Yeow Chua, Helen Y. Lee, Jimmy Lee, Rebecca Lee, Caroline Lim, Eugene Tay, Puay San Woon, Richard S.E. Keefe et al. · 2010 · Psychiatry Research
  16. Themes of unfulfilled agency and communion in life stories of patients with schizophrenia
    Tine Holm, Dorthe Kirkegaard Thomsen, Vibeke Bliksted · 2018 · Psychiatry Research
  17. Remote self-administration of digital cognitive tests using the Brief Assessment of Cognition: Feasibility, reliability, and sensitivity to subjective cognitive decline
    Alexandra S. Atkins, Michael Kraus, Matthew Welch, Zhenhua Yuan, Heather B. Stevens, Kathleen Anne Welsh-Bohmer, Richard S.E. Keefe · 2022 · Frontiers in Psychiatry
  18. Gender differences in the relationships among neurosteroid serum levels, cognitive function, and quality of life
    Chien-Yu Chen, Chih‐Ching Wu, Yu‐Chi Huang, Chi‐Fa Hung, Liang‐Jen Wang · 2018 · Neuropsychiatric Disease and Treatment
  19. Smooth pursuit eye movement deficits as a biomarker for psychotic features in bipolar disorder—Findings from the PARDIP study
    Svenja Brakemeier, Andreas Sprenger, Inga Meyhöfer, Jennifer E. McDowell, Leah H. Rubin, S. Kristian Hill, Matcheri S. Keshavan, Godfrey D. Pearlson, Carol A. Tamminga, Elliot S. Gershon et al. · 2019 · Bipolar Disorders
  20. Differential effects of age at illness onset on verbal memory functions in antipsychotic-naïve schizophrenia patients aged 12–43 years
    Birgitte Fagerlund, Christos Pantelis, Jens Richardt Møllegaard Jepsen, Jayachandra Mitta Raghava, Egill Rostrup, Marie Bjerregaard Thomas, Mette Ødegaard Nielsen, Kirsten Borup Bojesen, Karsten Gjessing Jensen, Marie Stentebjerg Decara et al. · 2020 · Psychological Medicine
  21. Deficits in Auditory and Visual Sensory Discrimination Reflect a Genetic Liability for Psychosis and Predict Disruptions in Global Cognitive Functioning
    Ian S. Ramsay, Michael‐Paul Schallmo, Bruno Biagianti, Melissa Fisher, Sophia Vinogradov, Scott R. Sponheim · 2020 · Frontiers in Psychiatry
  22. Improvements in Cognitive Performance With Computerized Training in Older People With and Without Cognitive Impairment: Synergistic Effects of Skills-Focused and Cognitive-Focused Strategies
    Philip D. Harvey, Matthew Zayas-Bazan, Lize Tibiriçá, Peter Kallestrup, Sara J. Czaja · 2021 · American Journal of Geriatric Psychiatry
  23. The association between cognitive deficits and prefrontal hemodynamic responses during performance of working memory task in patients with schizophrenia
    Shenghong Pu, Kazuyuki Nakagome, Masashi Itakura, Masaaki Iwata, Izumi Nagata, Koichi Kaneko · 2016 · Schizophrenia Research
  24. Impact of Cognitive Impairments on Health-Related Quality of Life in Schizophrenia
    Gurpreet Rekhi, Young Ern Saw, Keane Lim, Richard S.E. Keefe, Jimmy Lee · 2023 · Brain Sciences
  25. Association between gut permeability, brain volume, and cognition in healthy participants and patients with schizophrenia spectrum disorder
    Toon Anton Willem Scheurink, Jenny Borkent, Shiral S. Gangadin, Sahar El Aidy, René C.W. Mandl, Iris E. Sommer · 2023 · Brain and Behavior
  26. Corollary Discharge Dysfunction as a Possible Substrate of Anomalous Self-experiences in Schizophrenia
    Rosa M. Beño‐Ruiz‐de‐la‐Sierra, Antonio Arjona, Marta Hernández-García, Inés Fernández‐Linsenbarth, Álvaro Díez, Sabela Fondevila, Carolina Castaño, Francisco Muñoz, Javier Sanz-Fuentenebro, Alejandro Roig-Herrero et al. · 2023 · Schizophrenia Bulletin
  27. Differential effects of emotional information on interference task performance across the life span
    Haley M LaMonica · 2010 · Frontiers in Aging Neuroscience
  28. Increased frontal gray matter volume in individuals with prodromal psychosis
    Xiaoxiao Shan, Yangpan Ou, Pan Pan, Yudan Ding, Jin Zhao, Feng Liu, Jindong Chen, Wenbin Guo, Jingping Zhao · 2019 · CNS Neuroscience & Therapeutics
  29. Predictive value of premorbid IQ, negative symptoms, and age for cognitive and social functions in Japanese patients with schizophrenia: A study using the Japanese version of the Brief Assessment of Cognition in Schizophrenia
    Kazufumi Akiyama, Satoshi Saitô, Atsushi Saito, Yuji Ozeki, Takashi Watanabe, Kumiko Fujii, Gyo Honda, Kazutaka Shimoda · 2016 · Psychiatry Research
  30. The Impact of Aging, Psychotic Symptoms, Medication, and Brain-Derived Neurotrophic Factor on Cognitive Impairment in Japanese Chronic Schizophrenia Patients
    Kiyokazu Atake, Tomoyuki Nakamura, Nobuhisa Ueda, Hikaru Hori, Asuka Katsuki, Reiji Yoshimura · 2018 · Frontiers in Psychiatry
  31. Defining cognitive profiles of depressive patients using the Brief Assessment of Cognition in Affective Disorders
    Ruei-An Chen, Chun‐Yi Lee, Yu Lee, Chi‐Fa Hung, Yu‐Chi Huang, Pao‐Yen Lin, Sheng-Yu Lee, Liang‐Jen Wang · 2019 · PeerJ
  32. Deconstructing Cognitive Impairment in Psychosis With a Machine Learning Approach
    Robert Ali McCutcheon, Richard S.E. Keefe, Philip K. McGuire, André F. Marquand · 2024 · JAMA Psychiatry
  33. Applicability of the MATRICS Consensus Cognitive Battery in Singapore
    Attilio Rapisarda, Thomas F. Lim, Matthew Lim, Simon L. Collinson, Michael Kraus, Richard S.E. Keefe · 2013 · The Clinical Neuropsychologist
  34. A subtype of institutionalized patients with schizophrenia characterized by pronounced subcortical and cognitive deficits
    Qiannan Zhao, Hengyi Cao, Wenjing Zhang, Siyi Li, Yuan Xiao, Carol A. Tamminga, Matcheri S. Keshavan, Godfrey D. Pearlson, Brett A. Clementz, Elliot S. Gershon et al. · 2022 · Neuropsychopharmacology
  35. Probiotic Formulation for Patients With Bipolar or Schizophrenia Spectrum Disorder: A Double-Blind, Randomized Placebo-Controlled Trial
    Jenny Borkent, Magdalini Ioannou, Dorien Neijzen, Bartholomeus C. M. Haarman, Iris E. Sommer · 2024 · Schizophrenia Bulletin
  36. Effects of aerobic walking on cognitive function in patients with schizophrenia: A randomized controlled trial
    Yu‐Chi Huang, Chi‐Fa Hung, Su‐Ting Hsu, Pao‐Yen Lin, Yu Lee, Mian‐Yoon Chong, Chien-Chih Chen, Yu‐Hsin Kuo, Liang‐Jen Wang · 2020 · Journal of Psychiatric Research
  37. Do Symptoms and Cognitive Problems Affect the Use and Efficacy of a Web-Based Decision Support System for Smokers With Serious Mental Illness?
    Joelle C. Ferron, Mary F. Brunette, Susan R. McGurk, Haiyi Xie, Rochelle L. Frounfelker, Judith Α. Cook, Jessica A. Jonikas, Gregory J. McHugo · 2012 · Journal of Dual Diagnosis
  38. Refining the latent structure of neuropsychological performance in schizophrenia
    Max Lam, Simon L. Collinson, Goi Khia Eng, Attilio Rapisarda, Michael Kraus, Jimmy Lee, Siow Ann Chong, Richard S.E. Keefe · 2014 · Psychological Medicine
  39. 5-HT6 Receptor Antagonist as an Adjunct Treatment Targeting Residual Symptoms in Patients With Schizophrenia
    Morozova Ma, Denis S. Burminskiy, George E. Rupchev, T. A. Lepilkina, С. С. Потанин, Бениашвили Аллан Герович, Yan Lavrovsky, Natalia Vostokova, Alexander Ivaschenko · 2017 · Journal of Clinical Psychopharmacology
  40. Individualized Prediction of Prodromal Symptom Remission for Youth at Clinical High Risk for Psychosis
    Michelle Worthington, Jean Addington, Carrie E. Bearden, Kristin S. Cadenhead, Barbara A. Cornblatt, Matcheri S. Keshavan, Daniel H. Mathalon, Thomas H. McGlashan, Diana O. Perkins, William S. Stone et al. · 2021 · Schizophrenia Bulletin
  41. The impact of cannabidiol treatment on resting state functional connectivity, prefrontal metabolite levels and reward processing in recent-onset patients with a psychotic disorder
    Ruben van Boxel, Shiral S. Gangadin, Hella Janssen, Sanne J. van der Steur, Lucia J.C. van der Vinne, Lon Dortants, Teuntje A. D. Pelgrim, Luc W.R. Draisma, Ruth Tuura, Pim B. van der Meer et al. · 2023 · Journal of Psychiatric Research
  42. Relationship of Metacognition and Insight to Neural Synchronization and Cognitive Function in Early Phase Psychosis
    Bethany L. Leonhardt, Jenifer L. Vohs, Lisa A. Bartolomeo, Andrew C. Visco, William P. Hetrick, Amanda R. Bolbecker, Alan F. Breier, Paul Henry Lysaker, Brian F. O’Donnell · 2019 · Clinical EEG and Neuroscience
  43. Effects of motivation domains on social functioning in schizophrenia with consideration of the factor structure and confounding influences
    Takashi Uchino, Takahiro Nemoto, Akiko Kojima, Youji Takubo, Yumi Kotsuji, Eriko Yamaguchi, Taiju Yamaguchi, Naoyuki Katagiri, Naohisa Tsujino, Kuniaki Tanaka et al. · 2020 · Journal of Psychiatric Research
  44. Regressing to Prior Response Preference After Set Switching Implicates Striatal Dysfunction Across Psychotic Disorders: Findings From the B-SNIP Study
    S. Kristian Hill, James L. Reilly, Michael E. Ragozzino, Leah H. Rubin, Jeffrey R. Bishop, Ruben C. Gur, Elliot S. Gershon, Carol A. Tamminga, Godfrey D. Pearlson, Matcheri S. Keshavan et al. · 2014 · Schizophrenia Bulletin
  45. Carbon monoxide feedback in a motivational decision support system for nicotine dependence among smokers with severe mental illnesses
    Mary F. Brunette, Joelle C. Ferron, Robert E. Drake, Timothy S. Devitt, Pamela Geiger, Gregory J. McHugo, Jessica A. Jonikas, Judith Α. Cook · 2013 · Journal of Substance Abuse Treatment
  46. Could schizoaffective disorder, schizophrenia and bipolar I disorder be distinguishable using cognitive profiles?
    Chih‐Ken Chen, Chun‐Yi Lee, Yu Lee, Chi‐Fa Hung, Yu‐Chi Huang, Sheng-Yu Lee, Ming‐Chyi Huang, Mian‐Yoon Chong, Yi‐Chih Chen, Liang‐Jen Wang · 2018 · Psychiatry Research
  47. Selection for psychosocial treatment for youth at clinical high risk for psychosis based on the North American Prodrome Longitudinal Study individualized risk calculator
    Michelle Worthington, David J. Miklowitz, Mary P. O’Brien, Jean Addington, Carrie E. Bearden, Kristin S. Cadenhead, Barbara A. Cornblatt, Daniel H. Mathalon, Thomas H. McGlashan, Diana O. Perkins et al. · 2020 · Early Intervention in Psychiatry
  48. Emotion recognition latency, but not accuracy, relates to real life functioning in individuals at ultra-high risk for psychosis
    Louise Birkedal Glenthøj, Nikolai Albert, Birgitte Fagerlund, Tina Dam Kristensen, Christina Wenneberg, Carsten Rygaard Hjorthøj, Merete Nordentoft, Jens Richardt Møllegaard Jepsen · 2018 · Schizophrenia Research
  49. Associations between plasma clozapine/N-desmethylclozapine ratio, insulin resistance and cognitive performance in patients with co-morbid obesity and ultra-treatment resistant schizophrenia
    Kenya A. Costa-Dookhan, Tarek K. Rajji, Veronica Tran, Sylvie Bowden, Daniel J. Müller, Gary J. Remington, Sri Mahavir Agarwal, Margaret Hahn · 2021 · Scientific Reports
  50. Brain and muscle chemistry in myalgic encephalitis/chronic fatigue syndrome (ME/CFS) and long COVID: a 7T magnetic resonance spectroscopy study
    Beata R. Godlewska, Amy L. Sylvester, Uzay E. Emir, Ann L. Sharpley, William T. Clarke, S. R. Williams, Ana Jorge Gonçalves, Betty Raman, Ladislav Valkovič, Philip J. Cowen · 2025 · Molecular Psychiatry
  51. Lesion network guided delta frequency neuromodulation improves cognition in patients with psychosis spectrum disorders: A pilot study
    Willa Molho, Nicolas Raymond, Robert M. G. Reinhart, Rebekah L. Trotti, Shrey Grover, Matcheri S. Keshavan, Paulo L. Lizano · 2023 · Asian Journal of Psychiatry
  52. Do patients with high-functioning autism have similar social cognitive deficits as patients with a chronic cause of schizophrenia?
    Lotte Veddum, Heine Lund Pedersen, Anna-Sofie Lose Landert, Vibeke Bliksted · 2019 · Nordic Journal of Psychiatry
  53. Clinical insight and cognitive functioning as mediators in the relationships between symptoms of psychosis, depression, and suicide ideation in first-episode psychosis
    Lindsay A. Bornheimer, Derin J. Cobia, Juliann Li Verdugo, Joshua Holzworth, Matthew J. Smith · 2022 · Journal of Psychiatric Research
  54. A randomized controlled trial of add-on naproxen, simvastatin and their combination for the treatment of schizophrenia or schizoaffective disorder
    Mark Weiser, Linda W. Levi, Jin‐Young Park, Igor Nastas, Valentin Petre Matei, Michael H. Davidson, Ido Arad, Israel Dudkiewicz, John M. Davis · 2023 · European Neuropsychopharmacology
  55. Clinical characterization and differentiation of B-SNIP psychosis Biotypes: Algorithmic Diagnostics for Efficient Prescription of Treatments (ADEPT)-1
    Brett A. Clementz, Ishanu Chattopadhyay, Rebekah L. Trotti, David Parker, Elliot S. Gershon, S. Kristian Hill, Elena I. Ivleva, Sarah Keedy, Matcheri S. Keshavan, Jennifer E. McDowell et al. · 2023 · Schizophrenia Research
  56. The Continuous Performance Test, Identical Pairs: norms, reliability and performance in healthy controls and patients with schizophrenia in Singapore
    Attilio Rapisarda, Michael Kraus, Yi Wen Tan, Max Lam, Goi Khia Eng, Jimmy Lee, Mythily Subramaniam, Simon L. Collinson, Siow Ann Chong, Richard S.E. Keefe · 2014 · Schizophrenia Research
  57. Integrating psychopharmacology and cognitive remediation to treat cognitive dysfunction in the psychotic disorders
    Alice A. Medalia, Lewis A. Opler, Alice M. Saperstein · 2013 · CNS Spectrums
  58. Establishing the Brief Assessment of Cognition - Short form
    Max Lam, Mingyuan Wang, Wanping Huang, Goi Khia Eng, Attilio Rapisarda, Michael Kraus, Sim Kang, Richard S.E. Keefe, Jimmy Lee · 2017 · Journal of Psychiatric Research
  59. Neurocognitive clusters: A pilot study of young people with affective disorders in an inpatient facility
    Ashleigh M. Tickell, Elizabeth M. Scott, Tracey A Davenport, Frank Iorfino, Laura Ospina‐Pinillos, Kate Harel, Lisa Parker, Ian Bernard Hickie, Daniel Francis Hermens · 2018 · Journal of Affective Disorders
  60. Omega‐3 fatty acids and neurocognitive ability in young people at ultra‐high risk for psychosis
    Alison McLaverty, Kelly Allott, Maximus Berger, Robert Hester, Patrick D. McGorry, Barnaby Nelson, Connie Markulev, Hok Pan Yuen, Miriam R. Schäfer, Nilufar Mossaheb et al. · 2020 · Early Intervention in Psychiatry
  61. The relationship between cognitive deficits and impaired short-term functional outcome in clinical high-risk for psychosis participants: A machine learning and modelling approach
    Kate Haining, Gina Brunner, Ruchika Gajwani, Joachim Groß, Andrew Ian Gumley, Stephen M. Lawrie, Matthias Schwannauer, Frauke Schultze‐Lutter, Peter J. Uhlhaas · 2021 · Schizophrenia Research
  62. Predictors of functioning in treatment-resistant schizophrenia: the role of negative symptoms and neurocognition
    Yanhui Li, Mei San Ang, Jie Yin Yee, Yuen Mei See, Jimmy Lee · 2024 · Frontiers in Psychiatry
  63. Endothelial function, folate pharmacogenomics, and neurocognition in psychotic disorders
    Tyler Barrett Grove, Stephan Floyd Taylor, Gregory W. Dalack, Vicki L. Ellingrod · 2015 · Schizophrenia Research
  64. Screening for cognitive impairment in schizophrenia: Psychometric properties of the German version of the Screen for Cognitive Impairment in Psychiatry (SCIP-G)
    Gabriele Sachs, Iris Lasser, Scot E. Purdon, Andreas Erfurth · 2021 · Schizophrenia Research Cognition
  65. The Effect of Therapeutic Alliance on Attitudes Toward Psychiatric Medications in Schizophrenia
    Madeline Lim, Ziqiang Li, Huiting Xie, Bhing‐Leet Tan, Jimmy Lee · 2021 · Journal of Clinical Psychopharmacology
  66. Déficit cognitivo en la esquizofrenia: MATRICS Consensus Cognitive Battery
    Roberto Rodríguez–Jiménez, Alexandra Bagney, Marta Moreno-Ortega, Cristina García-Navarro, Ana Isabel Aparicio, Raúl López‐Antón, Jose de la Oliva, Miguel Ángel Jiménez Arriero, José Luis Santos, António Lobo et al. · 2012 · Revista de Neurología
  67. Neurocognitive Profiles of Methamphetamine Users: Comparison of Those With or Without Concomitant Ketamine Use
    Yi‐Chih Chen, Liang‐Jen Wang, Shih‐Ku Lin, Chih‐Ken Chen · 2015 · Substance Use & Misuse
  68. Association of the Synapse-Associated Protein 97 (SAP97) Gene Polymorphism With Neurocognitive Function in Schizophrenic Patients
    Xusan Xu, Chunmei Liang, Dong Lv, Jingwen Yin, Xudong Luo, Jiawu Fu, Haifeng Yan, Xia Zhou, Zhun Dai, Dongjian Zhu et al. · 2018 · Frontiers in Psychiatry
  69. Cognitive deficits among people with schizophrenia and prediabetes or diabetes
    Alexander Panickacheril John, Thynn Mya, Darren Haywood · 2023 · Acta Psychiatrica Scandinavica
  70. Serum levels of β-hydroxybutyrate and pyruvate, metabolic changes and cognitive function in patients with schizophrenia during antipsychotic treatment: a preliminary study
    Yu‐Chi Huang, Pao‐Yen Lin, Yu Lee, Chi‐Fa Hung, Su‐Ting Hsu, Chih‐Ching Wu, Liang‐Jen Wang · 2018 · Neuropsychiatric Disease and Treatment
  71. The Computerized Functional Skills Assessment and Training Program: Sensitivity to Global Cognitive Impairment, Correlations With Cognitive Abilities, and Factor Structure
    Philip D. Harvey, Daniela Bolivar Forero, Lauren B. Ahern, Lize Tibiriçá, Peter Kallestrup, Sara J. Czaja · 2020 · American Journal of Geriatric Psychiatry
  72. Real-time facial emotion recognition deficits across the psychosis spectrum: A B-SNIP Study
    Leah H. Rubin, Jiaxu Han, Jennifer Marie Coughlin, S. Kristian Hill, Jeffrey R. Bishop, Carol A. Tamminga, Brett A. Clementz, Godfrey D. Pearlson, Matcheri S. Keshavan, Elliot S. Gershon et al. · 2021 · Schizophrenia Research
  73. Brief Assessment of Cognition in Schizophrenia: Normative Data in an English-Speaking Ethnic Chinese Sample
    Goi Khia Eng, Max Lam, Yioe Ling Bong, Mythily Subramaniam, Dianne Bautista, Attilio Rapisarda, Michael Kraus, Jimmy Lee, Simon L. Collinson, SA Chong et al. · 2013 · Archives of Clinical Neuropsychology
  74. A pilot study: comparative research of social functioning, circadian rhythm parameters, and cognitive function among institutional inpatients, and outpatients with chronic schizophrenia and healthy elderly people
    Yu Kume, Takio Sugita, Kenya Oga, Kai Kagami, Hitomi Igarashi · 2014 · International Psychogeriatrics
  75. Raloxifene augmentation in men and women with a schizophrenia spectrum disorder: A study protocol
    Bodyl A. Brand, Janna N. de Boer, Sebastianus B. J. Oude Ophuis, Margot I. E. Slot, Bieke De Wilde, Kirsten Catthoor, Angelique J. Goverde, Pieter Roberto Bakker, Machteld C. Marcelis, Koen P. Grootens et al. · 2020 · Contemporary Clinical Trials Communications
  76. Automated clustering and switching algorithms applied to semantic verbal fluency data in schizophrenia spectrum disorders
    Chiara Barattieri di San Pietro, Claudio Luzzatti, Elisabetta Ferrari, Giovanni de Girolamo, Marco Marelli · 2023 · Language Cognition and Neuroscience
  77. Mediation Effects of Social Cognition on the Relationship between Neurocognition and Social Functioning in Major Depressive Disorder and Schizophrenia Spectrum Disorders
    Uchino, Takashi, Okubo, Ryo, Takubo, Youji, Aoki, Akiko, Wada, Izumi, Hashimoto, Naoki, Ikezawa, Satoru, Nemoto, Takahiro · 2023 · Journal of Personalized Medicine
  78. Improving prediction of psychosis in youth at clinical high-risk: pre-baseline symptom duration and cortical thinning as moderators of the NAPLS2 risk calculator
    Michelle Worthington, Meghan A. Collins, Jean Addington, Carrie E. Bearden, Kristin S. Cadenhead, Barbara A. Cornblatt, Matcheri S. Keshavan, Daniel H. Mathalon, Diana O. Perkins, William S. Stone et al. · 2023 · Psychological Medicine
  79. Comparing the influences of age and disease on the Brief Assessment of Cognition in Schizophrenia in Japanese patients with schizophrenia
    Norio Yasui‐Furukori, Ayako Kaneda, Takeshi Katagai, Norio Sugawara, Shoko Tsuchimine, Manabu Saito, Yasushi Sato, Hanako Furukori · 2013 · Neuropsychiatric Disease and Treatment
  80. Relationship of auditory electrophysiological responses to magnetic resonance spectroscopy metabolites in Early Phase Psychosis
    Lisa A. Bartolomeo, Andrew Martin Wright, Ruoyun Emily Ma, Tom A. Hummer, Michael Francis, Andrew C. Visco, Nicole F. Mehdiyoun, Amanda R. Bolbecker, William P. Hetrick, Ulrike Dydak et al. · 2019 · International Journal of Psychophysiology
  81. Serum Interleukin-6 in Schizophrenia: Associations with Clinical and Sociodemographic Characteristics
    Tatyana Vladimirovna Zhilyaeva, Grigory V. Rukavishnikov, Elvira A. Manakova, Galina Elevna Mazo · 2023 · Consortium Psychiatricum
  82. Personal recovery in first-episode psychosis: Beyond clinical and functional recovery
    Isolde L. Maas, Marc M. Bohlken, Shiral S. Gangadin, Bram‐Sieben Rosema, Wim Veling, Nynke Boonstra, Lieuwe de Haan, Marieke Begemann, Sanne Koops · 2024 · Schizophrenia Research
  83. Evidence from comprehensive independent validation studies for smooth pursuit dysfunction as a sensorimotor biomarker for psychosis
    Inga Meyhöfer, Andreas Sprenger, David Derad, Dominik Grotegerd, Ramona Leenings, Elisabeth Johanna Leehr, Fabian Breuer, Marian Surmann, Karen Rolfes, Volker Arolt et al. · 2024 · Scientific Reports
  84. Categorical and Dimensional Approaches for Psychiatric Classification and Treatment Targeting: Considerations from Psychosis Biotypes
    Brett A. Clementz, Michal Assaf, John A. Sweeney, Elliot S. Gershon, Sarah Keedy, S. Kristian Hill, Elena I. Ivleva, Carol A. Tamminga, Jennifer E. McDowell, Matcheri S. Keshavan et al. · 2024 · Advances in neurobiology
  85. Differentiating biomarker features and familial characteristics of B-SNIP psychosis Biotypes
    David Parker, Rebekah L. Trotti, Jennifer E. McDowell, Sarah Keedy, Matcheri S. Keshavan, Godfrey D. Pearlson, Elliot S. Gershon, Elena I. Ivleva, Ling-Yu Huang, Kodiak Sauer et al. · 2025 · Translational Psychiatry
  86. The Chinese version of the Brief Assessment of Cognition in Affective Disorders: normative data of a Mandarin-speaking population
    Chun‐Yi Lee, Sheng-Yu Lee, Yu‐Chi Huang, Chi‐Fa Hung, Yu Lee, Meng-I Lee, Liang‐Jen Wang · 2017 · The Clinical Neuropsychologist
  87. Altered Autonomic Function in Individuals at Clinical High Risk for Psychosis
    Anna Kocsis, Ruchika Gajwani, Joachim Groß, Andrew Ian Gumley, Stephen M. Lawrie, Matthias Schwannauer, Frauke Schultze‐Lutter, Tineke Grent-‘t-Jong, Peter J. Uhlhaas · 2020 · Frontiers in Psychiatry
  88. Reviewing the Potential Therapeutic Approaches Targeting the Modulation of Gastrointestinal Microflora in Schizophrenia
    Ilinca-Bianca Nita, Ovidiu‐Dumitru Ilie, Alin Stelian Ciobica, Luminiţa Diana Hrițcu, Irina Dobrin, Bogdan Doroftei, Romeo Dobrin · 2022 · International Journal of Molecular Sciences
  89. The double-blind randomized placebo-controlled trial of N-acetylcysteine use in schizophrenia: preliminary results
    A.S. Pyatoykina, Tatyana Vladimirovna Zhilyaeva, Ilya Vladimirovich Semennov, Georgy Aleksandrovich Mishanov, Anna Sergeevna Blagonravova, Galina Elevna Mazo · 2020 · S S Korsakov Journal of Neurology and Psychiatry
  90. A Randomized Control Trial of Cognitive Compensatory Training (CCT) and Computerized Interactive Remediation of Cognition-Training for Schizophrenia (CIRCuiTS)
    F. Dark, Victoria Gore-Jones, Ellie Newman, Maddison Wheeler, V. Demonte, K. Northwood · 2022 · Frontiers in Psychiatry
  91. Timing of cannabis exposure relative to prodrome and psychosis onset in a community-based first episode psychosis sample
    Emily R. Kline, Maria Ferrara, Fangyong Li, Deepak Cyril D’Souza, Matcheri S. Keshavan, Vinod H. Srihari · 2022 · Journal of Psychiatric Research
  92. Linked brain connectivity patterns with psychopathological and cognitive phenotypes in drug-naïve first-episode schizophrenia
    Hui Juan Sun, Wenjing Zhang, Hengyi Cao, Huaiqiang Sun, Jing Dai, Siyi Li, Jiaxin Zeng, Wei Xia, Biqiu Tang, Qiyong Gong et al. · 2022 · Psychoradiology
  93. Neuropsychological functioning and suicidal behaviours in patients with first‐episode psychosis: A systematic review
    Teresa Sánchez‐Gutiérrez, Sara Barbeito, Rocı́o Gómez-Juncal, Elisa Rodríguez‐Ortega, Juan Antonio Becerra‐García, Ana Calvo · 2022 · Acta Psychiatrica Scandinavica
  94. Abstinence and Use of Community-Based Cessation Treatment After a Motivational Intervention Among smokers with Severe Mental Illness
    Joelle C. Ferron, Timothy S. Devitt, Gregory J. McHugo, Jessica A. Jonikas, Judith Α. Cook, Mary F. Brunette · 2016 · Community Mental Health Journal
  95. The brief assessment of cognition in affective disorders: Normative data for the Italian population
    Maria Gloria Rossetti, Carolina Bonivento, Marco Garzitto, Elisabetta Caletti, Cinzia Perlini, Sara Piccin, Matteo Lazzaretti, Veronica Marinelli, Michela Sala, Vera Abbiati et al. · 2019 · Journal of Affective Disorders
  96. Cross-cultural comparison of theory of mind deficits in patients with schizophrenia from China and Denmark: different aspects of ToM show different results
    Katrine Ingeman Beck, Arndis Simonsen, Huiling Wang, Liuqing Yang, Yuan Zhou, Vibeke Bliksted · 2020 · Nordic Journal of Psychiatry
  97. Association between global visual scanning and cognitive function in schizophrenia
    Wei Huang, Chen Chen, Xianjun Chen, Chen Xing, Jingli Gan, Xiquan Zhu, Jian Xu, Liqiong Zhao, Jie Zhou, Rui Yang et al. · 2021 · Asian Journal of Psychiatry
  98. A Retrospective Study on the Relationship Between Cognitive Function and Social Function in Patients With Schizophrenia
    Takamitsu Shimada, Genyo Kobayashi, Yoshihiro Saeki, Chikako Mizukoshi, Kazuo Chikazawa, Katsutoshi Nokura, Mitsuru Hasegawa, Tamami Maeda, Yoshiki Maeda, Yasuhiro Kawasaki · 2022 · Journal of Clinical Medicine Research
  99. Improving outcome of treatment-resistant schizophrenia: effects of cognitive remediation therapy
    Francesca Martini, Marco Spangaro, Margherita Bechi, Giulia Agostoni, Mariachiara Buonocore, Jacopo Sapienza, Daniela Nocera, Chiara Ave, Federica Cocchi, Roberto Cavallaro et al. · 2023 · European Archives of Psychiatry and Clinical Neuroscience
  100. Cognitive discrepancies, motivation and subjective well-being in people with schizophrenia
    Daniel J. Krzyzanowski, Ofer Agid, Vina M. Goghari, Gary J. Remington · 2021 · Schizophrenia Research Cognition